載入...
Technological and Therapeutic Advances in Advanced Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for approximately 10−15% of all lung cancers. The prognosis is poor with median survival in the advanced stage remaining at around 12 months. Despite applying every known therapeutic approach, no major breakthrough has improved the overall survival in...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI AG
2019-10-01
|
| 叢編: | Cancers |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/2072-6694/11/10/1570 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|